ACTIVE_NOT_RECRUITING

A Closed Loop, Doctor to Patient, Mobile Application for Depression in People With Multiple Sclerosis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The researchers want to find out if an electronic application called MS CATCH can enhance patients' and doctors' experiences during and in between clinical visits. MS CATCH is a smartphone-based tool which allows patients to enter their mood related symptoms at regular intervals, which is then available to their Neurologist in their electronic medical record. The neurologist is also able to view additional information from their medical record, and receives alerts for changes reported by the patient that raise concern for the patient's mental health.

Official Title

Care Technology to Ascertain, Treat, and Engage the Community to Heal Depression in Patients With Multiple Sclerosis: Closing the Gaps in Depression Care for People With MS By Closing the Information Loop

Quick Facts

Study Start:2023-08-01
Study Completion:2026-08-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05865405

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of MS (relapsing or progressive) by 2017 McDonald Criteria18
  2. * Ages 18 to 80
  3. * PHQ-9 score of 5-19
  4. * Any MS therapy, or no treatment
  5. * California resident to enable clinical telemedicine visits if warranted during the study visit
  1. * Cognitive dexterity or visual impairment (typically defined as corrected acuity less than 20/70) that, in the opinion of the study neurologist (RB), would put the participant at risk or limit their ability to adhere to the study protocol
  2. * Inability to provide informed consent
  3. * Psychotic disorders: bipolar disorder, schizophrenia, schizoaffective disorder
  4. * Substance abuse that in the treating neurologist's perspective could influence the patient's safety on study or adherence to study protocol
  5. * Another co-morbid CNS diagnosis eg. TBI

Contacts and Locations

Principal Investigator

Riley Bove, MD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

Weill Institute for Neurosciences, University of California, San Francisco
San Francisco, California, 94158
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Riley Bove, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-01
Study Completion Date2026-08-15

Study Record Updates

Study Start Date2023-08-01
Study Completion Date2026-08-15

Terms related to this study

Keywords Provided by Researchers

  • MS
  • Multiple Sclerosis
  • Depression
  • Depressed

Additional Relevant MeSH Terms

  • Multiple Sclerosis
  • MS
  • Depression